This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store.Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.

PRESTO-3 Study Overview

Acromegaly / Neuroendocrine Tumours (NETs) File
22 pages

A guide summarising the PRESTO-3 study, which evaluated nurse and patient preferences for injectable Somatostatin analogues.

LAN-UK-000490 | November 2024

PRESTO-3 Study Overview
Explore more Acromegaly / Neuroendocrine Tumours (NETs) Resources

Explore more Acromegaly / Neuroendocrine Tumours (NETs) Resources

Browse